These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3125103)

  • 1. [Effect of anti-D prevention on the incidence of irregular erythrocyte antibodies in pregnant patients].
    Finger H; Drechsler HJ; Wirsing von König CH
    Immun Infekt; 1987 Nov; 15(6):208-15. PubMed ID: 3125103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 3. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience.
    Moncharmont P; Juron Dupraz F; Vignal M; Rigal D; Meyer F; Debeaux P
    Arch Gynecol Obstet; 1991; 248(4):175-80. PubMed ID: 1910321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the effectiveness of the anti-D-prevention at the Göttingen University Gynecological Clinic from 1969 to 1972].
    Hähn N; Gallasch EH; Wilken H
    Zentralbl Gynakol; 1976; 98(1):39-44. PubMed ID: 814743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Errors in the prevention of Rh incompatibility].
    Dmoch E
    Acta Haematol Pol; 1988; 19(1-2):59-61. PubMed ID: 3149111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Successes and failures in rhesus-prophylaxis].
    Speiser P
    Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects of prenatal prevention of rhesus incompatibility].
    Maas DH
    Beitr Infusionsther; 1992; 30():425-30. PubMed ID: 1284752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current problems of blood group incompatibility in pregnancy].
    Wilken H
    Zentralbl Gynakol; 1988; 110(1):1-11. PubMed ID: 3281396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is rhesus prophylaxis indicated also with positive antibodies?].
    Behrens O
    Z Geburtshilfe Neonatol; 1996; 200(6):246. PubMed ID: 9081755
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current aspects of fetomaternal immunizations].
    Dupont S; Ruf H; Blanc B; Adrai J; Conte M; Delpont PJ; Chau C
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):689-93. PubMed ID: 3936153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.